Fatty liver spiral: Health Minister J P Nadda says ICMR study shows over 84% of IT sector employees in Hyderabad have the condition
More than 84 per cent of IT sector employees in Hyderabad had increased liver fat, indicating a condition called the MAFLD (or Metabolic Dysfunction Associated Fatty Liver Disease). This is basically fatty liver brought on by obesity, diabetes and high blood pressure. The IT employees seem to be a vulnerable group because of their largely sedentary lifestyles, poor diet and lack of sleep.
The study — based on data from 345 IT employees — found that 76.5 per cent had high levels of LDL (low-density lipoprotein or bad) cholesterol, 70.7 per cent were obese and 20.9 per cent had higher than normal fasting blood glucose levels. While the study was published in the journal 'Scientific Reports' earlier this year, it was reported recently in the Parliament by Union Health Minister JP Nadda. He was answering a question by AIMIM member Asaduddin Owaisi on the burden of MAFLD and what the government was doing to combat the challenge.
Sale
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
7 hours ago
- Time of India
Out of 6 cr people screened in 17 states, Sickle Cell Disease found in 2.16 lakh: JP Nadda in LS
New Delhi: Union Health Minister J P Nadda informed the Lok Sabha on Friday that 6.04 crore people in the 17 identified tribal-dominated states, including Maharashtra, have been screened for Sickle Cell Disease (SCD) till July 28, out of which 2,16,118 have been confirmed as diseased. Replying to a question, the health minister said the National Sickle Cell Anaemia Elimination Mission (NSCAEM) was launched by Prime Minister Narendra Modi from Madhya Pradesh on July 1, 2023 to eliminate SCD. The objectives of the mission are provision of affordable, accessible and quality care to all SCD patients, reduction in the prevalence of the disease through awareness creation, targeted screening of seven crore people till 2025-26 in the age group of 0-40 years in the affected districts of tribal areas and counselling through collaborative efforts of central ministries and state governments, he said. Screenings are conducted under NSCAEM at all health facilities from district hospitals up to Ayushman Arogya Mandir (AAM) level, Nadda said, adding, "As on 28.07.2025, a total of 6,04,50,683 population in the 17 identified tribal dominated states including Maharashtra have been screened, out of which 2,16,118 have been confirmed as diseased." Patients living with SCD are provided with services and facilities to improve their quality of life through AAMs, which include follow-up of individuals with the disease at frequent intervals, counselling regarding lifestyle management, pre-marriage and pre-natal decisions, nutritional supplementation support through the distribution of folic acid tablets, and management of crisis symptoms, as well as referral to higher-level facilities. As of July 28, 2,62,67,997 genetic counselling ID cards have been distributed in the country, Nadda said. Hydroxyurea has been included in the National Health Mission (NHM) Essential Drugs List at Sub-Health Centres, Primary Health Centres (PHC), Urban PHC, Community Health Centres (CHC) and District Hospitals to address the issue of access to medicine, the minister said. Under NHM, financial support is provided for the procurement of Hydroxyurea, to reduce the out-of-pocket expenditure borne by sickle cell anaemia patients. The Ministry of Health and Family Welfare (MoHFW) has issued guidelines for cost norms for the establishment of centres of excellence (CoE) on SCD funded by the Ministry of Tribal Affairs (MoTA) in various states. To date, 15 CoEs have been approved in the country by MoTA, Nadda informed. Through MoTA, awareness and counselling material have been developed and disseminated to the states and Union Territories (UTs). Through monthly Ayushman Arogya Shivirs, awareness is raised for various health programmes including SCD. The ministry provides technical and financial support to the states and UTs for conducting screenings and procurement of drugs for sickle cell anaemia, based on the proposals received in the form of programme implementation plans (PIPs) under NHM.
The Hindu
14 hours ago
- The Hindu
Women, kin of deceased donors to get priority in organ transplant, says govt.
To address gender imbalance among organ transplant recipients and encourage donations, the National Organ & Tissue Transplant Organisation (NOTTO) has issued a 10-point advisory stating that women patients and relatives of deceased donors awaiting organ transplants will get priority as beneficiaries. In his recent letter to States and Union Territories, Anil Kumar, director of NOTTO, said that the objective of the inclusions is to make provisions for 'additional points in the allocation criteria' for women patients in the waiting list to 'address gender disparity'. According to the Health Ministry, the existing allocation criteria for major organs and tissues — kidney, heart, liver, lungs, heart and cornea — have been prescribed by NOTTO for transparency and equity in the allocation system, giving preference to those whose requirement is more. The allocation criteria give priority according to the duration of the disease, period on waiting list, severity of illness, children, living donor now requiring transplant, and matching parameters such as blood group, age, size etc. for better outcome. The other factors include local utilisation of organs and geographical proximity of recipients. NOTTO maintains a digital national registry of organ recipients and donors. Patients needing transplant can register through their hospital in the national registry. Recently, Union Health Minister J.P. Nadda said that since the launch of Aadhaar-based NOTTO online pledge website in 2023, more than 3.3 lakh citizens have pledged to donate their organs, marking a historic moment in public participation. 'India achieved a milestone of performing over 18,900 organ transplants in 2024, the highest ever recorded in a single year, a significant leap from fewer than 5,000 transplants in 2013,'' he had said. In his latest communication, Dr. Kumar noted that all transplant hospitals and centres will have to mandatorily submit data of each donor and recipient of organs or tissues to a national registry maintained by NOTTO. Non-compliance would likely lead to legal action against such hospitals. NOTTO has asked State governments to create permanent posts for transplant coordinators at hospitals that perform organ transplantation or retrieval. 'It is advised that you develop facilities for organ and tissue retrieval in all trauma centres and register them as organ retrieval centres. Medical colleges have been encouraged to develop similar facilities in a phased manner,'' the letter said, while calling for training emergency responders and ambulance staff to identify potential deceased donors early, particularly among victims of road traffic accidents and stroke patients. Stressing the need to transform the organ donation and transplantation landscape in India, the letter has called for greater transparency, equity and dignity to the process and introduce measures to address longstanding challenges.
Economic Times
2 days ago
- Economic Times
Out of 6 cr people screened in 17 states, Sickle Cell Disease found in 2.16 lakh: JP Nadda in LS
IANS More than 6 crore people have been screened for sickle cell anaemia in the country, of which 2.16 lakh have been identified as diseased, Union Health Minister JP Nadda informed the Parliament on Friday. Union Health Minister J P Nadda informed the Lok Sabha on Friday that 6.04 crore people in the 17 identified tribal-dominated states, including Maharashtra, have been screened for Sickle Cell Disease (SCD) till July 28, out of which 2,16,118 have been confirmed as diseased. Replying to a question, the health minister said the National Sickle Cell Anaemia Elimination Mission (NSCAEM) was launched by Prime Minister Narendra Modi from Madhya Pradesh on July 1, 2023 to eliminate SCD. The objectives of the mission are provision of affordable, accessible and quality care to all SCD patients, reduction in the prevalence of the disease through awareness creation, targeted screening of seven crore people till 2025-26 in the age group of 0-40 years in the affected districts of tribal areas and counselling through collaborative efforts of central ministries and state governments, he said. Screenings are conducted under NSCAEM at all health facilities from district hospitals up to Ayushman Arogya Mandir (AAM) level, Nadda said, adding, "As on 28.07.2025, a total of 6,04,50,683 population in the 17 identified tribal dominated states including Maharashtra have been screened, out of which 2,16,118 have been confirmed as diseased." Patients living with SCD are provided with services and facilities to improve their quality of life through AAMs, which include follow-up of individuals with the disease at frequent intervals, counselling regarding lifestyle management, pre-marriage and pre-natal decisions, nutritional supplementation support through the distribution of folic acid tablets, and management of crisis symptoms, as well as referral to higher-level facilities. As of July 28, 2,62,67,997 genetic counselling ID cards have been distributed in the country, Nadda said. Hydroxyurea has been included in the National Health Mission (NHM) Essential Drugs List at Sub-Health Centres, Primary Health Centres (PHC), Urban PHC, Community Health Centres (CHC) and District Hospitals to address the issue of access to medicine, the minister said. Under NHM, financial support is provided for the procurement of Hydroxyurea, to reduce the out-of-pocket expenditure borne by sickle cell anaemia patients. The Ministry of Health and Family Welfare (MoHFW) has issued guidelines for cost norms for the establishment of centres of excellence (CoE) on SCD funded by the Ministry of Tribal Affairs (MoTA) in various states. To date, 15 CoEs have been approved in the country by MoTA, Nadda informed. Through MoTA, awareness and counselling material have been developed and disseminated to the states and Union Territories (UTs). Through monthly Ayushman Arogya Shivirs, awareness is raised for various health programmes including SCD. The ministry provides technical and financial support to the states and UTs for conducting screenings and procurement of drugs for sickle cell anaemia, based on the proposals received in the form of programme implementation plans (PIPs) under NHM.
